2017 Aug 24
Precision medicine in hematologic malignancies
John P. Leonard, M.D., discusses the advance of precision medicine across hematologic malignancies. Read more
2017 Aug 24
Early stage kidney cancer treatment
David M. Nanus, M.D., discusses treatment for patients with early-stage kidney cancer. Read more
2017 Aug 23
A million dollars in Movember money funds advanced prostate cancer research
Meyer prostate cancer experts led by Scott Tagawa, M.D., will use Movember funds to investigate a new treatment for an advanced form of the disease. Read more
2017 Aug 23
Research trial in NYC may change course of brain tumor treatment
Howard Fine, M.D., is determined to change the course of glioblastoma treatment, by testing drugs on 'mini brains' created in the lab. Read more
2017 Aug 18
Potential of immunotherapy in MCL landscape
Peter Martin, M.D., discusses the potential of modern immunotherapies in the landscape of mantle cell lymphoma (MCL). Read more
2017 Aug 18
Exploring the decreasing incidence of colon cancer in those over the age of 50
Manish A. Shah, M.D., discusses the decreasing incidence of colon cancer diagnosis in those over the age of 50. Read more
2017 Aug 15
Considering factors for upfront therapy in CLL
Richard R. Furman, M.D., discusses factors to consider when choosing upfront therapy for patients with chronic lymphocytic leukemia (CLL). Read more
2017 Aug 10
Inside NYP: Chief Resident Dr. Babacar Cisse
Profile of Babacar Cisse, M.D., Ph.D., a new assistant professor of neurosurgery who came to America with $26 in his pocket and achieved his dream of becoming a doctor. Read more
2017 Aug 09
Lung cancer: How to protect yourself from blood clots
Maria De Sancho, M.D., discusses the increased risk of deep vein thrombosis among cancer patients. Read more
2017 Aug 08
ASCT-related toxicities for patients with MCL
Peter Martin, M.D., discusses the toxicities related to stem cell transplantation for patients with mantle cell lymphoma (MCL). Read more
2017 Aug 08
Spotlight on Staff: Meet Dr. Ana Patricia Da Silva Gomes
Profile of postdoctoral researcher Ana Patricia Da Silva Gomes, Ph.D. Read more
2017 Aug 07
Exciting advancements in the field of mantle cell lymphoma
John P. Leonard, M.D., professor of medicine, discusses some of the exciting advancements taking place in the field of mantle cell lymphoma (MCL). Read more
2017 Aug 07
Patient selection for immunotherapy in gastric cancer
Manish A. Shah, M.D., joins a panel to discuss immunotherapy treatment for gastric cancer. Read more
2017 Aug 04
Challenges with CAR T-cell therapy in ALL
Gail Roboz, M.D., discusses the challenges clinicians are facing with chimeric antigen receptor (CAR) T-cell therapy in acute lymphoblastic leukemia (ALL). Read more
2017 Aug 04
Sequencing therapies for patients with multiple myeloma
Ruben Niesvizky, M.D. discusses sequencing agents for patients with multiple myeloma. Read more
2017 Aug 03
Second-generation BTK inhibitors in CLL
Richard R. Furman, M.D., discusses second-generation BTK inhibitors, such as acalabrutinib and BGB-3111 in chronic lymphocytic leukemia (CLL). Read more
2017 Aug 02
Skip the Bone Marrow Biopsy in Follicular Lymphoma?
Clinical trials in patients with follicular lymphoma (FL) mandate that patients undergo bone marrow biopsies (BMBs) at baseline and at subsequent points following treatment in order to monitor response, but the biopsies are unnecessary in most patients, argues Sarah Rutherford, M.D., and colleagues. Read more
2017 Aug 02
Does radiotherapy in unresectable pancreatic cancer add value?
John Ng, M.D., reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer. Read more
2017 Aug 02
Collaborative Research Initiative announces inaugural award winners
Four interdisciplinary teams of physicians and scientists from Weill Cornell Medicine have been announced as recipients of the Sandra and Edward Meyer Cancer Center's inaugural Collaborative Research Initiative pilot project grants. Read more
2017 Jul 31
Driving discovery: Two teams uncover new player in prostate cancer formation
Scientists at the Meyer Cancer Center and Englander Institute have identified ERF as a prostate cancer tumor suppressor gene. Read more
